person

Paal M.

Country
Norway
Department
N/A

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 16 partner sites.

Specializations

Oncology – Advanced Solid Tumors

Focus on advanced solid tumors across a spectrum of anatomical sites and molecular profiles.

  • KRAS G12C‑mutated non‑small cell lung cancer
  • high‑tumor mutational burden (TMB‑H) cancers
  • mismatch repair deficient (dMMR)/MSI‑H tumors
  • HPV‑positive oropharyngeal carcinoma
  • HER2‑positive gastric/gastroesophageal junction cancer

Encompasses both metastatic and locally advanced disease stages.

Hematology – Leukemia and Lymphoma

Engagement with a broad range of hematologic malignancies, including acute and chronic forms.

  • acute myeloid leukemia (AML)
  • acute lymphoblastic leukemia (ALL)
  • chronic myeloid leukemia (CML)
  • diffuse large B‑cell lymphoma (DLBCL)
  • mantle cell lymphoma (MCL)

Includes both treatment‑naïve and relapsed/refractory disease contexts.

Immunology – Autoimmune and Immune‑Mediated Disorders

Investigation of immune‑mediated diseases with emphasis on antibody‑driven and cellular mechanisms.

  • generalized myasthenia gravis
  • immune thrombocytopenia (ITP)
  • primary sclerosing cholangitis (PSC)
  • systemic lupus erythematosus (SLE)
  • rheumatoid arthritis

Targets both adult and pediatric patient populations.

Nephrology – Kidney Disease and Glomerulopathies

Specialization in renal disorders characterized by proteinuria and progressive loss of function.

  • immunoglobulin A nephropathy (IgAN)
  • chronic kidney disease stage 5
  • anemia of chronic kidney disease
  • proteinuric kidney disease
  • renal involvement in systemic vasculitis

Addresses both dialysis‑dependent and non‑dialysis cohorts.

Pulmonology – Interstitial Lung Disease and Pulmonary Vascular Disorders

Research directed at fibrotic and inflammatory lung conditions with high unmet need.

  • idiopathic pulmonary fibrosis (IPF)
  • progressive fibrosing interstitial lung disease (PF‑ILD)
  • pulmonary sarcoidosis
  • chronic obstructive pulmonary disease (COPD)
  • pulmonary hypertension associated with left‑heart disease

Includes both diagnostic and therapeutic investigations.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.